Thus, the main purpose of the present study is to evaluate the efficacy of Wnt7a overexpression combined with radiotherapy in NSCLC cell lines, because preclinical and clinical studies have reported that the combination of gene therapy and conventional anticancer therapy can improve therapeutic benefit (Fang and Roth, 2003). Here, WNT7A is linked to non-small cell lung carcinoma.